Overview
Pharmacokinetics, Efficacy and Safety Assessment of T2345 Compared With Active Comparator in Newly Diagnosed Patients With Open-angle Glaucoma or Ocular Hypertension
Status:
Completed
Completed
Trial end date:
2008-12-01
2008-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to assess the pharmacokinetics, efficacy and safety of T2345 versus an active comparator.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Laboratoires Thea
Criteria
Inclusion Criteria:- Untreated bilateral newly diagnosed patients with primary open angle glaucoma
Exclusion Criteria:
- Any ocular hypertension other than chronic open angle glaucoma